Association between UGT1A1*28 polymorphisms and clinical outcomes of irinotecan-based chemotherapies in colorectal cancer: a meta-analysis in Caucasians.
about
Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of OptionsRecent applications of chemosensitivity tests for colorectal cancer treatmentDevelopment and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous determination of irinotecan and its main metabolites in human plasma and its application in a clinical pharmacokinetic studyPrognostic value of chemotherapy-induced hematological toxicity in metastatic colorectal cancer patientsCisplatin combined with irinotecan or etoposide for untreated extensive-stage small cell lung cancer: A multicenter randomized controlled clinical trial.An internally and externally validated nomogram for predicting the risk of irinotecan-induced severe neutropenia in advanced colorectal cancer patientsOATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapyPredictive effects of bilirubin on response of colorectal cancer to irinotecan-based chemotherapy.Tissue banking, bioinformatics, and electronic medical records: the front-end requirements for personalized medicine.UGT1A1 polymorphisms in cancer: impact on irinotecan treatment.Predictive value of GSTP1 Ile105Val polymorphism in clinical outcomes of chemotherapy in gastric and colorectal cancers: a systematic review and meta-analysis.Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1*28 Patient Genotype.The prognostic impact of serum bilirubin in stage IV colorectal cancer patients.Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients.
P2860
Q26738655-3CD34286-17C2-4733-9BD6-65508642E00FQ26851075-702FEB6B-081D-4A45-A6AD-3092D710FC14Q28543429-8C28A6D2-D7E5-41ED-9F48-BB5D007623CEQ33413622-06DD0108-4F6F-4BA4-A9B4-D5C6C73EC73AQ33427471-0E59D359-105E-406A-84BD-346DFBAC19D3Q35603648-C5F4C5C5-76BA-4218-8AA7-F87C66C7A8DBQ35678729-FED64779-1545-4415-B9B6-945A501BA38FQ36815039-695FE4A6-3357-43B9-B042-09C389FFF200Q36931470-E7DB9D30-7D2D-4771-89E5-88990F8D8162Q37682812-F272ADEA-AC19-4EB1-9A39-B683D761A606Q38827826-D1CB63BA-8897-4D46-A1C3-9389D38BE43FQ43358640-A0D50812-F23F-40CF-AA3C-AABA52DFFEDCQ48247378-A90B362D-4C60-4B5C-8371-1E43675A056AQ48298629-E34595F8-E701-4B4B-9AF1-381E890ABB53
P2860
Association between UGT1A1*28 polymorphisms and clinical outcomes of irinotecan-based chemotherapies in colorectal cancer: a meta-analysis in Caucasians.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Association between UGT1A1*28 ...... a meta-analysis in Caucasians.
@ast
Association between UGT1A1*28 ...... a meta-analysis in Caucasians.
@en
Association between UGT1A1*28 ...... a meta-analysis in Caucasians.
@nl
type
label
Association between UGT1A1*28 ...... a meta-analysis in Caucasians.
@ast
Association between UGT1A1*28 ...... a meta-analysis in Caucasians.
@en
Association between UGT1A1*28 ...... a meta-analysis in Caucasians.
@nl
prefLabel
Association between UGT1A1*28 ...... a meta-analysis in Caucasians.
@ast
Association between UGT1A1*28 ...... a meta-analysis in Caucasians.
@en
Association between UGT1A1*28 ...... a meta-analysis in Caucasians.
@nl
P2093
P2860
P1433
P1476
Association between UGT1A1*28 ...... a meta-analysis in Caucasians.
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0058489
P407
P50
P577
2013-03-14T00:00:00Z